StonvexLoading…
StonvexStonvexStonvexCore line items from BBSI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.24B | $1.14B | $1.07B | $1.05B |
Operating Income | $62.16M | $59.78M | $60.65M | $58.98M |
Net Income | $54.45M | $52.99M | $50.61M | $47.27M |
EPS (Diluted) | $2.08 | $1.98 | $1.85 | $1.64 |
Total Assets | $779.07M | $745.51M | $721.54M | $686.94M |
Total Liabilities | $538.07M | $524.10M | $522.40M | $509.10M |
Cash & Equivalents | $95.03M | $55.37M | $71.17M | $91.42M |
Free Cash Flow OCF − CapEx | $47.18M | $-4.07M | $55.40M | $11.80M |
Shares Outstanding | 25.18M | 25.78M | 26.29M | 6.87M |